World's Best Scientists 2026 revealed!

Hirofumi Nakano publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Hirofumi Nakano sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

The last bar groups every scientist with 1,295 publications or more.

Hirofumi Nakano D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Hirofumi Nakano sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

The last bar groups every scientist with 159 D-Index or more.

Overview

Hirofumi Nakano is affiliated with Jichi Medical University in Japan. Their research primarily focuses on the field of Medicine, with particular attention to Infectious Diseases and Pharmacology as subfields of study.

The scientist's research work concentrates on topics related to COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Drug-Induced Hepatotoxicity and Protection.

Notable recent publications by Hirofumi Nakano include:

  • Autoimmune Hemolytic Anemia Induced by COVID-19 Vaccination, 2024, Kansenshogaku zasshi
  • Asbestos in organochlorine insecticide powder sprinkled between pages of antiquarian books in a library in Japan, 2024, Industrial Health
  • Efficacy of oral antivirals and combination therapy with remdesivir in hematological patients with COVID-19, 2025, Journal of Infection and Chemotherapy

Frequent co-authors include:

  • Yui Imai
  • Morihiro Inoue
  • Masao Hagihara
  • Hiroyoshi Hayashi
  • Takeshi Murakami

Hirofumi Nakano's work has appeared in the following publication venues:

  • Kansenshogaku zasshi
  • Industrial Health
  • Journal of Infection and Chemotherapy

Best Publications

  • Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.

    Eiji Kobayashi;Hirofumi Nakano;Makoto Morimoto;Tatsuya Tamaoki

  • Inhibition of protein kinase C by calphostin C is light-dependent.

    Robert F. Bruns;F.Dean Miller;Ronald L. Merriman;J.Jeffry Howbert

  • Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol.

    Sreenath V Sharma;Tsutomu Agatsuma;Hirofumi Nakano

  • STAUROSPORINE INHIBITS TYROSINE-SPECIFIC PROTEIN KINASE ACTIVITY OF ROUS SARCOMA VIRUS TRANSFORMING PROTEIN p60

    Hirofumi Nakano;Eiji Kobayashi;Isami Takahashi;Tatsuya Tamaoki

  • Potent and Specific Inhibitors of Protein Kinase C of Microbial Origin

    Tatsuya Tamaoki;Hirofumi Nakano

  • Hypericin and pseudohypericin specifically inhibit protein kinase C: Possible relation to their antiretroviral activity

    Isami Takahashi;Satoshi Nakanishi;Eiji Kobayashi;Hirofumi Nakano

  • UCN-01, a selective inhibitor of protein kinase C from Streptomyces.

    Isami Takahashi;Eiji Kobayashi;Kozo Asano;Mayumi Yoshida

  • Duocarmycin SA, a new antitumor antibiotic from Streptomyces sp.

    Michio Ichimura;Tatsuhiro Ogawa;Kei-Ichi Takahashi;Eiji Kobayashi

  • Duocarmycin A, a new antitumor antibiotic from Streptomyces.

    Isami Takahashi;Kei-Ichi Takahashi;Michio Ichimura;Makoto Morimoto

  • Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine

    Hirofumi Nakano;Satoshi Omura

  • UCN-01 and UCN-02, new selective inhibitors of protein kinase C. II. Purification, physico-chemical properties, structural determination and biological activities.

    Isami Takahashi;Yutaka Saitoh;Mayumi Yoshida;Hiroshi Sano

  • Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives.

    Yoshinori Yamashita;Noboru Fujii;Chikara Murakata;Tadashi Ashizawa

  • Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities.

    Eiji Kobayashi;Katsuhiko Ando;Hirofumi Nakano;Takao Iida

  • Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus.

    Yoshinori Yamashita;Shozou Kawada;Noboru Fujii;Hirofumi Nakano

  • Leinamycin, a new antitumor antibiotic from Streptomyces: producing organism, fermentation and isolation.

    Mitsunobu Kara;Kozo Asano;Isao Kawamoto;Toshimitsu Takiouchi

  • DC 107, a novel antitumor antibiotic produced by a Streptomyces sp.

    Mitsunobu Hara;Isami Takahashi;Mayumi Yoshida;Kozo Asano

  • UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation.

    Isami Takahashi;Kozo Asano;Isao Kawamoto;Tatsuya Tamaoki

  • Purification of docosahexaenoic acid by selective esterification of fatty acids from tuna oil with Rhizopus delemar lipase

    Yuji Shimada;Akio Sugihara;Hirofumi Nakano;Takashi Kuramoto

  • Radicicol Leads to Selective Depletion of Raf Kinase and Disrupts K-Ras-activated Aberrant Signaling Pathway

    Shiro Soga;Takako Kozawa;Hiroaki Narumi;Shiro Akinaga

  • Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.

    Yoshinori Yamashita;Tadashi Ashizawa;Makoto Morimoto;Jiro Hosomi

Frequent Co-Authors

Yuji Shimada
Yuji Shimada Osaka University
Akio Sugihara
Akio Sugihara Tokushima Bunri University
Makoto Kiso
Makoto Kiso Gifu University
Hideharu Ishida
Hideharu Ishida Gifu University
Yasuo Suzuki
Yasuo Suzuki Chubu University
Fusao Tomita
Fusao Tomita Hokkaido University
Keiko Nishikawa
Keiko Nishikawa Chiba University
Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
Satoshi Omura
Satoshi Omura Kitasato University
Yoichi Matsuda
Yoichi Matsuda Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens the door to a variety of related online degrees and career options. For those interested in a law-related path, exploring the paralegal degree can be a strategic move. This degree offers specialized knowledge that complements scientific expertise, particularly in regulatory and patent law sectors.

On the healthcare and pharmaceutical front, careers such as pharmaceutical sales require a keen understanding of chemistry and medicine. Information on how to become a pharmaceutical sales rep, including typical earnings, can be found under how much do pharmaceutical reps make. This path blends science with strong communication skills.

For those interested in higher clinical roles, becoming a pharmacist is a natural extension of a chemistry background. Detailed guidance on how to become a pharmacist salary helps prospective students understand the commitment and rewards involved in this career.

Additionally, earning an associate degree can provide a solid foundation for many related professions. The best online associate degree programs in criminal justice highlight how interdisciplinary education can lead to diverse roles that intersect with scientific knowledge, such as forensic chemistry or legal consulting.

Best Scientists Citing Hirofumi Nakano

Trending Scientists

Recently Published Articles